- $145.57m
- $149.00m
- $52.84m
Annual balance sheet for Apyx Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 30.9 | 10.2 | 43.7 | 31.7 | 31.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 21.3 | 18.3 | 14.2 | 15.6 | 16.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 60.7 | 43 | 70.4 | 56.4 | 58.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.87 | 7.59 | 7.15 | 6.74 | 6.62 |
| Other Long Term Assets | |||||
| Total Assets | 68.7 | 51.8 | 79.2 | 64.8 | 66.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.2 | 11.8 | 12.7 | 10.7 | 11.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15 | 14.2 | 52.5 | 50.6 | 52.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 53.7 | 37.6 | 26.7 | 14.2 | 14.5 |
| Total Liabilities & Shareholders' Equity | 68.7 | 51.8 | 79.2 | 64.8 | 66.8 |
| Total Common Shares Outstanding |